RecruitingNCT04850456

Treatment Strategy of Human Gamma Globulin on the Therapy for Intensively Ill Children With Inflammatory Storm

Treatment Strategy of Human Gamma Globulin in Children With Severe Infection Complicated With Inflammatory Storm : A Cohort Study


Sponsor

Children's Hospital of Fudan University

Enrollment

200 participants

Start Date

Oct 1, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The inflammatory storm in critically ill patients releases cytokines, causing systemic immune damage, which may be an important cause of multiple organ failure and even death. Inflammatory storms exacerbate the deterioration of the disease in those children. Gamma globulin may be an effective option to control inflammatory storms. However, this preliminary result needs to be verified from reliable and representative RCTs. In our study, we conducted a retrospective study on the use of gamma globulin and an unused control group. At present, the indications of IVIG are mainly focused on the neuromuscular system and the blood system. We hope to establish a more appropriate and operable evaluation table for the suitability of gamma globulin for clinical use.


Eligibility

Min Age: 29 DaysMax Age: 18 Years

Inclusion Criteria2

  • children hospitalized in PICU of Children's Hospital of Fudan University
  • Children With Severe Infection Complicated With Inflammatory Storm

Exclusion Criteria3

  • discharge within 48 hours
  • patients without informed consent
  • incomplete clinical and demographic data

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(2)

Children's Hospital of Fudan University

Shanghai, Shanghai Municipality, China

Children's Hospital of Fudan University

Shanghai, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04850456


Related Trials